A number of studies examining interactions of dendritic cell (DC)-specific ICAM-3 grabbing nonintegrin (DC-SIGN) with viral pathogens have relied on monocytic transfectants as models for primary DCs. Here we show that the presumed ''THP-1'' monocytic cells used in these studies are instead Raji B cells. Moreover, we demonstrate that true THP-1 cells do not support DC-SIGN-mediated HIV-1 transmission, whereas human B cell lines efficiently enhance this process. These data indicate that there are features common to B cells and DCs that facilitate transmission of HIV-1 and provide new insights toward the mechanism of DC-SIGN-mediated HIV-1 transmission. Published by Elsevier Inc.
Introduction
The identification of dendritic cell (DC)-specific ICAM-3 grabbing nonintegrin (DC-SIGN) as a key mediator of DC transmission of human immunodeficiency virus type 1 (HIV-1) to CD4+ T cells has provided an important molecular insight into this enigmatic process (Geijtenbeek et al., 2000a) . A defining aspect of DC-SIGN's interactions with HIV-1 is that it efficiently promotes infection in trans. Although it is not currently understood how the trans donation of HIV from donor to target cell takes place, DC-SIGN-mediated HIV transmission can be reconstructed with transformed cell lines facilitating examination of the underlying mechanism. To model and better understand DC-SIGN function in human monocyte-derived DCs (MDDCs), DC-SIGN transfectants of a cell line presumed to be monocytic THP-1 cells have been used in several publications to study interactions with viral pathogens including HIV-1/2, simian immunodeficiency virus (SIV), cytomegalovirus (CMV), Ebola virus, and Dengue virus (Baribaud et al., 2002; Bashirova et al., 2001 Bashirova et al., , 2003 Geijtenbeek et al., 2000a Geijtenbeek et al., , 2000b Gummuluru et al., 2002; Halary et al., 2002; Kwon et al., 2002; Lin et al., 2003; Navarro-Sanchez et al., 2003; Spear et al., 2003; Tassaneetrithep et al., 2003; Trumpfheller et al., 2003; Wu et al., 2002a Wu et al., , 2002b . However, in our efforts to define cell types that were permissive for DC-SIGN-mediated HIV-1 transmission, we recognized that ''THP-1'' cells that have been used in these studies were neither THP-1 cells nor any other monocytic line. Instead, these cells are derived from Raji B cells. Significantly, THP-1 monocytes do not support DC-SIGN-mediated HIV-1 transmission, whereas Raji B cells and other human B cell lines efficiently promote this process. These results suggest that previous studies of DC-SIGN function obtained using the misidentified B cell line need to be carefully reconsidered, and they also provide important insight into the mechanism of DC-SIGN-mediated HIV-1 trans infection.
Results

B-THP-1 cells are phenotypically and functionally distinct from THP-1 cells
Here we refer to the misidentified ''THP-1'' cells as B-THP-1 cells to reflect their presumed THP-1 origin. Initial examination of B-THP-1 cells revealed that this presumed monocytic cell line did not express endogenous CD4. Because most monocytic cells express CD4, we examined other THP-1 cell lines obtained from the ATCC and NCI for CD4 expression. These cells, in contrast, expressed low levels of CD4 (Table 1 ). In addition, examination of THP-1 ATCC cells and THP-1 NCI revealed that 10-15% of the cells expressed low levels of endogenously encoded DC-SIGN ( Fig. 1A , left panels). In contrast, B-THP-1 cells and Raji cells, a human B cell reference line, were uniformly negative for endogenous expression of DC-SIGN ( Fig. 1A, left panels) .
To test the ability of these cells to transmit HIV-1 mediated by DC-SIGN, we transduced the B-THP-1, Raji, THP-1 ATCC , and THP-1 NCI cells with retroviral vectors that encoded human DC-SIGN cDNA and obtained stable cell populations expressing high levels of DC-SIGN ( Fig.  1A , right panels). To our surprise, only the B-THP-1/DC-SIGN and the Raji/DC-SIGN cells efficiently supported DC-SIGN-mediated HIV-1 transmission, which was enhanced nearly 500-fold compared with the parental cell controls ( Fig. 1B) . Despite similar or higher levels of DC-SIGN expression present on the THP-1 ATCC /DC-SIGN and THP-1 NCI /DC-SIGN cells, these lines did not noticeably stimulate transmission of HIV-1 to CD4+ T cells ( Fig. 1B) or GHOST/X4/R5 indicator cells (data not shown).
The discordance in DC-SIGN-mediated HIV-1 transmission function exhibited by the different cell lines prompted further characterization. We examined these cells for the presence of cell surface markers that distinguish lineages of hematopoietic cells. All cells were uniformly negative for CD2, CD3, CD16, and CD40 ligand, indicating that the B-THP-1 cells are not derived from T or NK cells. However, only the THP-1 ATCC and THP-1 NCI cells expressed other cell surface markers that are consistent with a monocytic lineage, including CD4, CD11c, CD13, CD14, and CD33 (Table 1) . Instead, we found that B-THP-1 cells express CD5, CD10, CD19, CD20, CD21, and CD22, which are consistent with cells of a human B cell origin. Raji cells were virtually identical to B-THP-1 cells with regards to cell surface markers; whereas B-THP-1 cells were phenotypically distinct from the THP-1 ATCC , THP-1 NCI cells, and other transformed monocytic cell lines (Table 1 and data not shown). Expression of DC-SIGN in B-THP-1, THP-1 ATCC , THP-1 NCI , and Raji cells did not influence expression of the markers examined in Table 1 (data not shown).
B-THP-1 cells are EBV-positive
Because many immortalized human B cells are transformed with the Epstein -Barr virus (EBV), we assayed for the presence of EBV in B-THP-1 cells. Diagnostic polymerase chain reaction (PCR) analysis for the EBNA1 gene revealed the presence of EBV in B-THP-1, Raji, and the human B line NC-37 cells (348-bp product). In contrast, the EBNA1 gene was not detected in the THP-1 reference lines, Ramos B cells (an EBV-negative, Burkitt's lymphoma line, Klein et al., 1975) , or other human non-B cell lines that we examined including Hut78, Jurkat, HL-60, U937, and K562 cells.
B-THP-1 cells are genotypically identical to Raji cells
To determine whether the numerous phenotypic differences observed between B-THP-1 cells and reference THP-1 cell lines reflected a different origin of the cells or were the result of different experimental manipulation, we genotypically compared B-THP-1, Raji, THP-1 ATCC , THP-1 NCI , NC-37, and Ramos cells. Analysis of the polymorphic HLA class I loci revealed that THP-1 ATCC and THP-1 NCI cells were genetically identical at the three HLA class I loci, HLA-A, -B, and -C, but were distinct from B-THP-1, Raji, NC-37, and Ramos cells ( Table 2) . In contrast, B-THP-1 and Raji cells were identical by HLA class I analysis and distinct from two other human 
Expression of each marker was evaluated by cell surface staining with specific mAbs and compared with isotype-matched IgG controls. Cell population expression levels indicated as +++, ++, +, and +/ À demonstrated a mean fluorescence of antibody staining greater than 250, 50, 10, or 7.5, respectively. Isotype control stainings typically displayed a mean fluorescence intensity of 5 in the FL-2 channel using a Becton -Dickinson FACSCalibur instrument. B cell lines that were assayed (Table 2 ). In addition, genotyping of highly polymorphic microsatellite DNA at 10 loci (2-761-5, 2-890.7, 2-995.3, 4-1114.5, 2-1483.7, 2-1683.6, 2-1725.6, 2-1909.4 , NP1TT14Z1, NP12B1) and the killer cell Ig-like receptor (KIR) at five loci (2DL1-5, 2DS1-5, 3DL1-3, 3DS1, KIR2DP1) confirmed that THP-1 ATCC and THP-1 NCI cells were identical to one another, but distinct from B-THP-1 cells, which were identical to Raji cells (data not shown).
Human B cells support DC-SIGN-mediated HIV-1 transmission
To examine whether other human B cell lines support the DC-SIGN-mediated HIV-1 transmission, we obtained NC-37/DC-SIGN and Ramos/DC-SIGN stable transductants and tested these cells in the HIV-1 transmission assay. Similar to B-THP-1/DC-SIGN and Raji/DC-SIGN cells, NC-37/DC-SIGN and Ramos/DC-SIGN were able to transmit HIV-1 to CD4+ T cells (Fig. 1C ). HIV-1 transmission efficiency of the different B lines correlated with DC-SIGN expression levels (data not shown). Notably, DC-SIGN-negative NC-37 parental cells captured and transmitted HIV-1 20-fold better than the B-THP-1 parental line.
Discussion
Our examination of cells previously thought to be the ''THP-1'' monocytic line (Geijtenbeek et al., 2000a) has revealed that these cells are actually derived from the Raji B cell line. Indeed, Raji cells obtained from the ATCC are phenotypically and genetically indistinguishable from the B-THP-1 cells. In addition, like B-THP-1/DC-SIGN cells, human B cell lines such as Raji cells, NC-37, and Ramos cells engineered to express DC-SIGN potently transmit HIV-1 to target cells in the co-culture. In marked contrast, we found that bona fide THP-1 monocytic cells engineered to express DC-SIGN do not support HIV-1 transmission to target cells. These results have important implications for the current DC-SIGN literature that has utilized the misidentified cells.
Although prior studies utilizing the misidentified DC-SIGN transductants often used what were likely matched parental cells as a control line (Baribaud et al., 2002; Bashirova et al., 2001 Bashirova et al., , 2003 Geijtenbeek et al., 2000a Geijtenbeek et al., , 2000b Gummuluru et al., 2002; Halary et al., 2002; Kwon et al., 2002; Lin et al., 2003; Navarro-Sanchez et al., 2003; Spear et al., 2003; Tassaneetrithep et al., 2003; Trumpfheller et al., 2003; Wu et al., 2002a Wu et al., , 2002b , use of a B cell line instead of a monocytic cell line could result in misinterpretation of observed data. B cell physiology differs in important ways from other antigenpresenting cells. For example, synaptic junctions between B cells and T cells are qualitatively different from those that form between monocytes and T cells (Bromley et al., 2001; Creusot et al., 2002) , and B cell signaling processes are distinct from those present within monocytic cells.
As an example, two recent papers using these misidentified cells (Navarro-Sanchez et al., 2003; Tassaneetrithep et al., 2003) concluded that DC-SIGN enhances Dengue virus infection of human DC. Whereas Dengue virus is not known to infect THP-1 cells, it does infect human B cells (Lin et al., 2002) . Although use of DC-SIGN-expressing Raji cells (called Raji cells here on) as a model system to mimic Dengue virus interactions with DCs does not invalidate this work, it could affect the interpretation of these data. Minimally, these results should now be reconfirmed with other transformed cell types that express DC-SIGN. The unanticipated use of B cells may also provide insight regarding other flaviviruses examined in the later study that were unexpectedly found to infect ''THP-1'' parental cells (Navarro-Sanchez et al., 2003) .
Although it is conspicuous that THP-1 monocytes are unable to support DC-SIGN transmission of HIV-1, our data suggest that there are properties conserved between human B cells and primary DCs that are required for DC-SIGN transmission of HIV-1. In addition to Raji cells, several other human B cell lines also appear to be permissive for this transmission process. It was recently reported that the human B cell line Namalwa supports DC-SIGN-mediated HIV-1 transmission (Bobardt et al., 2003) . In our report, we observed that NC-37 and Ramos B cell lines support DC-SIGN-mediated HIV-1 transmission. Because Ramos cells are not infected by EBV, these data indicate that DC-SIGN transmission of HIV-1 by B cells does not require EBV transformation. Significantly, we observed that NC-37 parental cells appear to possess DC-SIGN-independent mechanisms for HIV-1 binding and transmission. This transmission process was not impaired by DC-SIGN monoclonal antibodies or soluble mannan (data not shown) and may represent an alternative route by which B cells can capture and transmit HIV-1.
Similar to these observations, primary human B cells are capable of transmitting immune-complexed HIV-1 to CD4+ T cells (Jakubik et al., 2000; Moir et al., 2000) . Expression of DC-SIGN in B cell lines presumably provides an alternate route for these cells to capture HIV-1 particles. After virus capture, these lines are highly effective vehicles for HIV-1 transmission to CD4+ cells. Thus, our data are consistent with previous findings that suggested that human B cells that complex HIV-1 via antibody, complement, or other routes may be significant contributors to the replication and dissemination of HIV-1 in vivo (Jakubik et al., 2000; Moir et al., 2000) . It is of note that follicular dendritic cells (FDC) capture HIV-1 using related mechanisms and are highly proficient in the transmission of this virus (Burton et al., 2002; Heath et al., 1995) . It will be of interest to compare B cells, FDCs, and MDDCs to determine whether conserved mechanisms of cell -cell communication have been coopted by HIV-1 for its transmission (McDonald et al., 2003) .
Despite the number of studies using the misidentified ''THP-1'' cells, many observations obtained with these cells have in fact extended our understanding of DC-SIGN function. Significantly, Raji/DC-SIGN transductants appear to recapitulate the functional behavior of DC-SIGN expressed on primary MDDCs (Geijtenbeek et al., 2000a (Geijtenbeek et al., , 2000b . Clearly, future studies with Raji/DC-SIGN transfectants should be interpreted in light of their B lineage origin. There may also be unexpected benefits from the discovery that B cells expressing DC-SIGN are effective disseminators of HIV-1 in that examination of the parallels between B cell and MDDC physiology will further our understanding of cell-mediated virus transmission and HIV-1 pathogenesis in vivo.
Materials and methods
Cells ''THP-1'' (B-THP-1) parental cells have been previously described (Geijtenbeek et al., 2000a) . THP-1 ATCC cells (ATCC number TIB-202), Raji cells (ATCC number CCL-86), and NC-37 cells (ATCC number CCL-214) were purchased from the American Type Culture Collection (ATCC, Manassas, VA). THP-1 NCI cells were obtained from the laboratory of Howard Young at the National Cancer Institute (NCI). Ramos cells were obtained from Catherine Smith and Amrie Grammer at the National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Stable DC-SIGN-expressing cell lines derived from parental B-THP-1, THP-1 ATCC , THP-1 NCI , Raji, NC-37, and Ramos cells were generated by transduction of the parental cells with MX-DC-SIGN retroviral vectors (Wu et al., 2002b) followed by fluorescence-activated cell sorting (FACS) to obtain high levels of DC-SIGN expression. The human embryonic kidney cell line HEK293T, the human T cell line Hut/CCR5, and HIV indicator GHOST/X4/R5 cell lines have been previously described (Wu et al., 2002a (Wu et al., , 2002b .
Antibodies
Fluorescein isothiocyanate (FITC) or phycoerythrin (PE)conjugated mouse anti-human mAbs against the following molecules were used: DC-SIGN (clone 120507) (R&D Systems, Minneapolis, MN); monocytic makers: CD4, CD11b, CD11c, CD13, CD14, CD33; B lineage markers: CD5, CD10, CD19, CD20, CD21, CD22; T cell or NK cell markers: CD2, CD3, CD16, CD40; and other makers: HLA-DR (MHC II); CD11a (LFA-1a); CD18 (LFA-1b), CD34, CD40, CD50 (ICAM-3), CD54 (ICAM-1), CD58 (LFA-3), CD69, CD80 (B7.1), CD83, CD86 (B7.2), CD102 (ICAM-2) (mAbs were purchased from Caltag Laboratories, Burlingame, CA and BD-PharMingen, San Diego, CA). Detailed mAb information is available upon request. FACS staining was performed as previously described (Wu et al., 2002b) .
Virus stocks
Single-round infectious, pseudotyped HIV-1 stocks (HIV-Luc/ADA) were generated by calcium phosphate cotransfections of HEK293T cells with the proviral vector plasmid NL-Luc-E À R À (HIV-Luc) containing a firefly luciferase reporter gene and an expression plasmid for the R5tropic HIV-1 ADA envelope glycoprotein as described (Wu et al., 2002a (Wu et al., , 2002b . Viral stocks were evaluated by limiting dilution on GHOST/X4/R5 cells.
HIV-1 infection assays
HIV-1 capture and transmission assays were performed as described previously (Wu et al., 2002a (Wu et al., , 2002b . In brief, donor cells (2.5 Â 10 5 ) were incubated with 1 Â 10 5 infectious units of HIV-Luc/ADA in a total volume of 400 Al for 3 h at 37 jC to allow adsorption of the virus. After 3 h, cells were washed with 1 ml of phosphate-buffered saline (PBS) and co-cultured with Hut/CCR5 target cells (1 Â 10 5 ) in the presence of 10 Ag of polybrene in 1 ml of culture medium. Cell lysates were obtained 2 days after infection and analyzed for luciferase activity using a commercially available assay kit (Promega, Madison, WI).
Genotyping analyses
Genomic DNA prepared with Genomic-tip 20 G (Qiagen, Valencia, CA) from different cell lines was genotyped by sequencing of the HLA class I loci (http://www.ihwg. org/protocols/protocol.htm). In addition, comparison of microsatellite DNA at 10 loci with greater than 75% heterozygosity (Martin et al., 1998) and KIR loci were also performed as previously described (Martin et al., 2002) .
PCR analyses of EBV
PCR amplification of the EBV nuclear antigen 1 (EBNA1) gene using 5V -GGT CGC CGG TGT GTT CGT ATA TGG-3V as a sense primer and 5V-GCG GCA GCC CCT TCC ACC ATA G-3Vas an antisense primer was performed as described (Muschen et al., 2000) .
